Last €55.71 EUR
Change Today -2.11 / -3.65%
Volume 20.0
ILU On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 4:50 AM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

illumina inc (ILU) Snapshot

Open
€56.13
Previous Close
€57.82
Day High
€56.13
Day Low
€55.62
52 Week High
05/20/13 - €57.82
52 Week Low
06/22/12 - €30.43
Market Cap
--
Average Volume 10 Days
273.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ILLUMINA INC (ILU)

Related News

No related news articles were found.

illumina inc (ILU) Details

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company’s sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia’s; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

2,400 Employees
Last Reported Date: 02/15/13
Founded in 1998

illumina inc (ILU) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $753.2K
Senior Vice President and General Manager of ...
Total Annual Compensation: $449.7K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $412.9K
Senior Vice President and General Manager of ...
Total Annual Compensation: $379.4K
Compensation as of Fiscal Year 2012.

illumina inc (ILU) Key Developments

Illumina Inc. Launches BaseSpace Apps

Illumina Inc. announced the full commercial availability of BaseSpace, the company's genomics cloud computing and storage platform. BaseSpace Apps is now out of beta status, and includes a full-fledged e-commerce system that allows customers to quickly and easily purchase Illumina and third-party bioinformatics applications (apps). BaseSpace e-commerce transactions are based on BaseSpace iCredits, a medium of exchange that can be purchased and spent within BaseSpace. BaseSpace has rapidly become a valuable platform for bioinformatics app developers. During the beta period, users launched individual BaseSpace apps more than 4,000 times. Now, with BaseSpace iCredits, developers can easily add e-commerce functionality to their apps, leveraging Illumina's complete payment solution. Through the BaseSpace ecosystem, a diverse collection of new apps are now available for Illumina's MiSeq and HiSeq systems. For example, Elsevier Publishing, the world's leading publisher of scientific and health information, has released a BaseSpace app that enables users to submit data directly into the peer-review publication process.

Illumina Inc. Announces Partnerships to Automate Truseq(R) and Nextera(R) Sample Preparation Kits

Illumina Inc. announced it is collaborating with leading providers of liquid handling robotic platforms to develop automation methods for its best-in-class TruSeq and Nextera Sample Preparation kits. Initial partners in this effort are Beckman Coulter Life Sciences, Eppendorf, Hamilton Robotics, PerkinElmer, and Tecan. These partnerships, and the resulting methods, reflect Illumina's commitment to creating the simplest, most efficient next-generation sequencing (NGS) workflows, and represent an important step towards enabling complete, end-to-end solutions for customers. Under the agreements, sample preparation kits sold by Illumina will be automated by the partners, who will develop, distribute and install the methods on customers' robots, as well as provide technical support. Illumina will assist during development, testing and promotion of the methods.

Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM

Illumina Inc. Presents at UBS Global Healthcare Conference, May-20-2013 11:30 AM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Marc A. Stapley, Chief Financial Officer and Senior Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILU:GR €55.71 EUR -2.11

ILU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.58.70 CHF -0.10
Avago Technologies Ltd $34.59 USD +0.15
BioMerieux €74.70 EUR +0.35
QIAGEN NV €14.47 EUR +0.02
Siemens Ltd 598.90 INR -1.05
View Industry Companies
 

Industry Analysis

ILU

Industry Average

Valuation ILU Industry Range
Price/Earnings 92.2x
Price/Sales 7.4x
Price/Book 6.8x
Price/Cash Flow 74.5x
TEV/Sales 5.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit www.illumina.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.